Up next in our ARS ROCKET @RadoncROVER series— a unique opportunity to learn about medicolegal topics from these two experts! Join us on 2/17! Sign up at https://t.co/OWmamw3jAi 🧑🏽⚖️🥼
🔔Call for Leadership Roles🔔
Medical students, Residents, and early career Physicians (≤5 years), join our leadership and help develop ROCKET programming, task force initiatives, and ARS Annual Meeting events. #MedEd#radonc
‼️Please Apply by 3/31/23‼️
https://t.co/8Dvt7gLEKE
🚨Register for this exciting upcoming webinar on Pregnancy and Family planning!🚨
@ACRORadOnc 🤝@S_W_R_O 🤝@ArsRocket 🤝@RadoncROVER
😲🤯🤩🤗
✍️sign up today at https://t.co/cspHjzroDi
Attention medical students applying to #radonc this year❕Sign up for this session and Q&A on finalizing your rank list. Hope to see you there! 🤛🏼 https://t.co/mL6Iw5vWDn
Want to learn more about Loyola's Radiation Oncology Residency Program?
We are hosting two virtual meet and greets this September!
9/12@ 6 pm CST https://t.co/2XPh3ZSQUO
9/28@ 6 pm CST https://t.co/fxXVpqhLgo
We look forward to meeting you!
Fantastic session on leadership and team building @RadiumSociety by Dr. Paul Harari and Dr. Zachary Morris from the University of Wisconsin! #ARS2022#ROCKET
📢#Radonc Residents: ROVER 2.0 and ARS ROCKET present:
Nearing the End Zone: Polishing your CV, Cover Letter, and Job Talk
10/8/21 12 pm PST/3 pm EST
Sign up:
https://t.co/1Io5DrQk6f
After 39 days of radiation treatment, today was my last day! If you have a moment, I jotted some thoughts of gratitude for these good folks, and reflected on the importance of health insurance; you can read them HERE: https://t.co/KCyeJmEgeB
Welcoming new @RutgersCancer faculty and celebrating those recognized with promotions and awards of tenure at our annual faculty recognition event earlier this week!
@ManyamMD is best described as hard work converging on raw talent. For savvy chairs and recruiters in twitter sphere, note that she is a PGY-5. #ASTRO2018
Jessika Contreras (@JessikaContrer1) will be presenting "Eliminating Post-operative Radiation to the Pathologically Node Negative Neck: Long-Term Results of a Propective Phase II Study" #ASTRO18 (2/7)